Cargando…
Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies
OBJECTIVES: Serum autoantibodies are pivotal for the early detection of systemic autoimmune rheumatic diseases such as Systemic Sclerosis (SSc) and Poly/Dermatomyositis (PM/DM), and in some cases are associated with organ complications such as interstitial lung disease (ILD). A paradigmatic example...
Autores principales: | Ceribelli, Angela, Isailovic, Natasa, De Santis, Maria, Gorlino, Carolina, Satoh, Minoru, Selmi, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388402/ https://www.ncbi.nlm.nih.gov/pubmed/32743530 http://dx.doi.org/10.1016/j.jtauto.2020.100049 |
Ejemplares similares
-
Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
por: Ceribelli, Angela, et al.
Publicado: (2023) -
Antigen Reactivity and Clinical Significance of Autoantibodies Directed Against the Pyruvate Dehydrogenase Antigen Complex in Patients With Connective Tissue Disease
por: Ceribelli, Angela, et al.
Publicado: (2022) -
Personalized medicine in rheumatology: the paradigm of serum autoantibodies
por: Sirotti, Silvia, et al.
Publicado: (2017) -
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review
por: Tonutti, Antonio, et al.
Publicado: (2022) -
Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis
por: Motta, Francesca, et al.
Publicado: (2023)